Somatic copy number gains in MYC, BCL2, and BCL6 identifies a subset of aggressive alternative-DH/TH DLBCL patients
Open Access
- 9 November 2020
- journal article
- research article
- Published by Springer Nature in Blood Cancer Journal
- Vol. 10 (11) , 1-8
Abstract
Double/triple hit lymphoma (DH/TH), known as high-grade B-cell lymphoma (HGBL), is an aggressive diffuse large B cell lymphoma (DLBCL), defined as having concurrent MYC, BCL2, and/or BCL6 gene rearrangements. While gene rearrangements represent significant genetic events in cancer, copy number alterations (CNAs) also play an important role, and their contributions to rearrangements have yet to be fully elucidated. Using FISH and high-resolution CNA data, we defined the landscape of concurrent gene rearrangements and copy gains in MYC, BCL2, and BCL6, in a cohort of 479 newly diagnosed DLBCL. We also show that concurrent translocations and copy number alterations, in combinations similar to DH/TH, identify a unique subset of DLBCL, alternative DH/TH, that have survival outcomes similar to DH/TH DLBCL patients.Keywords
Funding Information
- U.S. Department of Health & Human Services | National Institutes of Health (P50-CA097274, R01-CA212162, U01-CA195568)
- U.S. Department of Health & Human Services | National Institutes of Health
- U.S. Department of Health & Human Services | National Institutes of Health
This publication has 30 references indexed in Scilit:
- High level MYC amplification in B-cell lymphomas: is it a marker of aggressive disease?Blood Cancer Journal, 2020
- Amplification of 9p24.1 in diffuse large B-cell lymphoma identifies a unique subset of cases that resemble primary mediastinal large B-cell lymphomaBlood Cancer Journal, 2019
- Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomesNature Medicine, 2018
- Genetic and Functional Drivers of Diffuse Large B Cell LymphomaCell, 2017
- The 2016 revision of the World Health Organization classification of lymphoid neoplasmsBlood, 2016
- Rearrangement ofMYCIs Associated With Poor Prognosis in Patients With Diffuse Large B-Cell Lymphoma Treated in the Era of RituximabJournal of Clinical Oncology, 2010
- Increased MYC gene copy number correlates with increased mRNA levels in diffuse large B-cell lymphomaHaematologica, 2010
- Stromal Gene Signatures in Large-B-Cell LymphomasNew England Journal of Medicine, 2008
- MYC translocation and an increased copy number predict poor prognosis in adult diffuse large B‐cell lymphoma (DLBCL), especially in germinal centre‐like B cell (GCB) typeHistopathology, 2008
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingNature, 2000